Answers are grounded in this paper and cite their sources.
We read with great interest the article by Kimmann et al. [1], evaluating Model of End-Stage Liver Disease (MELD)-derived prognostic models in 1,621 patients undergoing TIPS for refractory ascites. The authors report only modest accuracy of refitted MELD-Na (reMELD-Na) for the primary endpoint of 90-day death or liver transplantation (AUC 0.636), with inferior performance compared to MELD-Na and MELD 3.0. These findings are highly timely, as reMELD-Na became the new standard allocation score within the Eurotransplant region in May 2025.
No takes yet. Share an insight, caveat, or question.
Quickert et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: